# Chronic atrial and intestinal dysrythmia syndrome: A late‐onset intestinal pseudo‐obstruction and cardiac dysfunction due to an SGO1 mutation

**Authors:** Linda Adouane, Pierre Poinsot, Julie Castilloux, Dorothée Dal Soglio, Christophe Faure

PMC · DOI: 10.1002/jpr3.70060 · JPGN Reports · 2025-07-03

## TL;DR

A rare genetic mutation in SGO1 causes late-onset intestinal and heart issues in children, requiring long-term care and monitoring.

## Contribution

Identifies a late-onset form of intestinal pseudo-obstruction linked to SGO1 mutations and associated cardiac and neurological complications.

## Key findings

- Eight children with SGO1 mutations showed late-onset intestinal pseudo-obstruction and cardiac dysrhythmia.
- All patients required parenteral nutrition and some needed ileostomies and pacemakers due to sinus dysfunction.
- Neurological follow-up is recommended due to cerebral small vessel disease observed in adults with the mutation.

## Abstract

Pediatric intestinal pseudo‐obstruction (PIPO) is a rare, heterogeneous, and severe gut motility disorder. In 2014, Chetaille et al. described chronic atrial and intestinal dysrhythmia (CAID) syndrome associated with a recessive SGO1 mutation (p.Lys23Glu) linking it to both intestinal pseudo‐obstruction and cardiac dysrhythmia. This study aimed to describe the clinical and nutritional features and outcomes of pediatric patients with the homozygous SGO1 (p.Lys23Glu) mutation.

We retrospectively enrolled children under 18 years with PIPO and homozygous (p.Lys23Glu) SGO1 mutation.

Eight patients were included (five girls), two were first‐degree relatives. All exhibited a typical PIPO clinical presentation, but with a later onset than usually seen in primary PIPO (median age: 6.3 years). Contrast studies revealed massively distended small bowel and colon in all patients. Antroduodenal and/or colonic manometry, performed in six patients, revealed a neuropathic pattern. A full‐thickness intestinal biopsy showed variable fibrosis of the smooth muscle internal layer associated with an abnormal presence of Cajal cells within the muscular layers. All patients required parenteral nutrition (PN) at a median age of 11.8 years. Five patients needed an ileostomy. At 18 years, one patient was off PN. Three patients developed sinus dysfunction: one at the time of PIPO diagnosis and two later. All required pacemakers. One patient died in her twenties secondary to cardiac complications.

Recessive SGO1 mutation is a form of late onset PIPO associated with sinus dysfunction. Long‐term outcome is unclear. Cardiac, intestinal, and neurologic follow‐up is recommended as cerebral small vessel disease has been described in adults.

In 2014, the chronic atrial and intestinal dysrhythmia (CAID) syndrome associated with a recessive SGO1 mutation was decribed as a progressive failure of pacemaking tissues in both gastrointestinal and cardiac systems.

In 2014, the chronic atrial and intestinal dysrhythmia (CAID) syndrome associated with a recessive SGO1 mutation was decribed as a progressive failure of pacemaking tissues in both gastrointestinal and cardiac systems.

Children exhibit a typical pediatric intestinal pseudo‐obstruction (PIPO) clinical presentation but with a later onset than usually seen in primary PIPO.We recommend testing for SGO1 mutations in children presenting with (1) PIPO with sinus dysfunction (bradycardia), (2) isolated PIPO, or (3) sinus dysfunction associated with symptoms of intestinal dysmotility.Cerebral small vessel disease has been described in adults and supports the need of neurologic follow‐up in patients with SGO1 mutation.

Children exhibit a typical pediatric intestinal pseudo‐obstruction (PIPO) clinical presentation but with a later onset than usually seen in primary PIPO.

We recommend testing for SGO1 mutations in children presenting with (1) PIPO with sinus dysfunction (bradycardia), (2) isolated PIPO, or (3) sinus dysfunction associated with symptoms of intestinal dysmotility.

Cerebral small vessel disease has been described in adults and supports the need of neurologic follow‐up in patients with SGO1 mutation.

## Linked entities

- **Genes:** SGO1 (shugoshin 1) [NCBI Gene 151648]
- **Diseases:** intestinal pseudo-obstruction (MONDO:0002803)

## Full-text entities

- **Genes:** SGO1 (shugoshin 1) [NCBI Gene 151648] {aka CAID, NY-BR-85, SGO, SGOL1}
- **Diseases:** fibrosis (MESH:D005355), PIPO (MESH:D007418), CAID (OMIM:616201), cerebral small vessel disease (MESH:D059345), sinus dysfunction (MESH:C563513), cardiac complications (MESH:D006331), cardiac dysrhythmia (MESH:D001145), neuropathic (MESH:D009437), syndrome (MESH:D013577), gut motility disorder (MESH:D015835)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Lys23Glu

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12611616/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12611616/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12611616/full.md

---
Source: https://tomesphere.com/paper/PMC12611616